SLRX NASDAQ
Salarius Pharmaceuticals, Inc.
1W: -0.5%
1M: -25.4%
3M: -82.9%
1Y: -97.4%
3Y: -99.5%
5Y: -100.0%
$0.84
Last traded 2025-12-31 — delisted
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Balance Sheet Trends
Total Assets
$3M
-54.1% ▼
5Y CAGR: -26.3%
Total Liabilities
$2M
+16.3% ▲
5Y CAGR: -14.5%
Shareholders Equity
$2M
-71.4% ▼
5Y CAGR: -32.2%
Cash & Investments
$2M
-58.7% ▼
5Y CAGR: -8.2%
Total Debt
$222K
-23.4% ▼
5Y CAGR: -15.1%
Net Debt
-$2M
+60.6% ▲
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $11M | $29M | $12M | $6M | $2M |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 |
| Cash & ST Investments | $11M | $29M | $12M | $6M | $2M |
| Net Receivables | $4M | $0 | $2M | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 | $0 |
| Other Current Assets | $138K | $173K | $168K | $151K | $222K |
| Total Current Assets | $16M | $30M | $15M | $7M | $3M |
| Property, Plant & Equip. | $23K | $8K | $0 | $0 | $0 |
| Goodwill & Intangibles | $9M | $9M | $0 | $0 | $0 |
| Long-Term Investments | $0 | $2M | $0 | $0 | $0 |
| Other Non-Current Assets | $247K | $186K | $131K | $67K | $35K |
| Total Non-Current Assets | $9M | $11M | $131K | $67K | $35K |
| Total Assets | $25M | $41M | $15M | $7M | $3M |
| — Liabilities — | |||||
| Accounts Payable | $2M | $2M | $3M | $603K | $937K |
| Short-Term Debt | $477K | $0 | $0 | $290K | $222K |
| Deferred Revenue | $0 | $0 | $0 | $0 | $0 |
| Other Current Liabilities | $59K | $0 | $0 | $0 | $0 |
| Total Current Liabilities | $3M | $2M | $4M | $1M | $2M |
| Long-Term Debt | $0 | $0 | $0 | $0 | $0 |
| Other Non-Current Liab. | $0 | $0 | $0 | $0 | $0 |
| Total Non-Current Liabilities | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $3M | $2M | $4M | $1M | $2M |
| — Equity — | |||||
| Common Stock | $2K | $5K | $225 | $393 | $144 |
| Retained Earnings | -$19M | -$32M | -$64M | -$76M | -$82M |
| Accumulated OCI | $0 | $0 | $0 | $0 | $0 |
| Total Stockholders Equity | $22M | $39M | $10M | $5M | $2M |
| Total Liabilities & Equity | $25M | $41M | $15M | $7M | $3M |
| — Key Metrics — | |||||
| Total Debt | $477K | $0 | $0 | $290K | $222K |
| Net Debt | -$11M | -$29M | -$12M | -$6M | -$2M |
| Total Investments | $0 | $2M | $0 | $0 | $0 |